Abstract
One of the major hurdles in liver gene and cell therapy is availability of ex vivo-expanded hepatocytes. Pluripotent stem cells are an attractive alternative. Here, we show that hepatocyte precursors can be isolated from male germline cell-derived pluripotent stem cells (GPSCs) using the hepatoblast marker, Liv2, and induced to differentiate into hepatocytes in vitro. These cells expressed hepatic-specific genes and were functional as demonstrated by their ability to secrete albumin and produce urea. When transplanted in the liver parenchyma of partially hepatectomised mice, Liv2-sorted cells showed regional and heterogeneous engraftment in the injected lobe. Moreover, approximately 50% of Y chromosomepositive, GPSC-derived cells were found in the female livers, in the region of engraftment, even one month after cell injection. This is the first study showing that Liv2-sorted GPSCsderived hepatocytes can undergo long lasting engraftment in the mouse liver. Thus, GPSCs might offer promise for regenerative medicine. Copyright:
Cite
CITATION STYLE
Fagoonee, S., Famulari, E. S., Silengo, L., Tolosano, E., & Altruda, F. (2015). Long term liver engraftment of functional hepatocytes obtained from germline cell-derived pluripotent stem cells. PLoS ONE, 10(8). https://doi.org/10.1371/journal.pone.0136762
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.